Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Vaginal Cuff Pap Smear Screening After Endometrial Cancer Treatment

Evidence-Based Recommendations for Post-Endometrial Cancer Surveillance

  • Most endometrial cancer recurrences occur within the first 3 years after treatment, requiring more frequent follow-up during this period 1, 2
  • The recommended follow-up schedule consists of:
    • Every 3-4 months for the first 3 years 1, 2
    • Every 6 months during years 4 and 5 1, 2
    • Annually thereafter 2
  • Clinical evaluation should focus on history and physical/gynecological examination, as these are most effective for detecting potentially curable vaginal or pelvic recurrences 2
  • Routine technical examinations such as Pap smears of the vaginal cuff have not demonstrated benefit in post-endometrial cancer surveillance 1, 2

Risk-Based Approach to Follow-Up

  • The primary goal of follow-up should be early detection of isolated vaginal or pelvic recurrences that may be amenable to curative treatment 2
  • Clinical examination remains the cornerstone of surveillance, as most symptomatic recurrences present with vaginal bleeding, discharge, or pelvic pain 2

Common Pitfalls to Avoid

  • Failure to maintain the recommended follow-up schedule, particularly during the first 3 years when recurrence risk is highest 1, 2
  • Neglecting thorough clinical examination, which remains the most effective method for detecting potentially curable recurrences 2